Pharmacological inhibition allows high selectivity for inhibition of homomeric TRPC6 channels than for heteromeric channels in AKI, particularly compared to targeting TRPC6 using Trpc6−/− animals. This evidence concerns the gene TRPC6 and acute kidney injury.